Erratum to ‘Adjuvant endocrine therapy in HER2-positive breast cancer patients: systematic review and meta-analysis’: [ESMO Open Volume 6, Issue 2, April 2021, 100088] (ESMO Open (2021) 6(2), (S2059702921000454), (10.1016/j.esmoop.2021.100088))

S. Peleg Hasson; M. R. Brezis; E. Shachar; S. S. Shachar; I. Wolf; A. Sonnenblick

doi:10.1016/j.esmoop.2021.100158

Erratum to ‘Adjuvant endocrine therapy in HER2-positive breast cancer patients: systematic review and meta-analysis’: [ESMO Open Volume 6, Issue 2, April 2021, 100088] (ESMO Open (2021) 6(2), (S2059702921000454), (10.1016/j.esmoop.2021.100088))

S. Peleg Hasson, M. R. Brezis, E. Shachar, S. S. Shachar, I. Wolf, A. Sonnenblick^*

^*Corresponding author for this work

Clinical Departments

Research output: Contribution to journal › Comment/debate

Abstract

The publisher regrets that at the time the article was published parts of Figure 2A and Figure 3 were missing. This has now been corrected and the correct figures appear below. [Figure presented] [Figure presented] The publisher would like to apologise for any inconvenience caused.

Original language	English
Article number	100158
Journal	ESMO Open
Volume	6
Issue number	3
DOIs	https://doi.org/10.1016/j.esmoop.2021.100158
State	Published - Jun 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.esmoop.2021.100158

Fingerprint

Dive into the research topics of 'Erratum to ‘Adjuvant endocrine therapy in HER2-positive breast cancer patients: systematic review and meta-analysis’: [ESMO Open Volume 6, Issue 2, April 2021, 100088] (ESMO Open (2021) 6(2), (S2059702921000454), (10.1016/j.esmoop.2021.100088))'. Together they form a unique fingerprint.

Cite this

Peleg Hasson, S., Brezis, M. R., Shachar, E., Shachar, S. S., Wolf, I., & Sonnenblick, A. (2021). Erratum to ‘Adjuvant endocrine therapy in HER2-positive breast cancer patients: systematic review and meta-analysis’: [ESMO Open Volume 6, Issue 2, April 2021, 100088] (ESMO Open (2021) 6(2), (S2059702921000454), (10.1016/j.esmoop.2021.100088)). ESMO Open, 6(3), [100158]. https://doi.org/10.1016/j.esmoop.2021.100158

@article{193b783e8abb486eb5af9629643cd338,

title = "Erratum to {\textquoteleft}Adjuvant endocrine therapy in HER2-positive breast cancer patients: systematic review and meta-analysis{\textquoteright}: [ESMO Open Volume 6, Issue 2, April 2021, 100088] (ESMO Open (2021) 6(2), (S2059702921000454), (10.1016/j.esmoop.2021.100088))",

abstract = "The publisher regrets that at the time the article was published parts of Figure 2A and Figure 3 were missing. This has now been corrected and the correct figures appear below. [Figure presented] [Figure presented] The publisher would like to apologise for any inconvenience caused.",

author = "{Peleg Hasson}, S. and Brezis, {M. R.} and E. Shachar and Shachar, {S. S.} and I. Wolf and A. Sonnenblick",

note = "Publisher Copyright: {\textcopyright} 2021 The Author(s)",

year = "2021",

month = jun,

doi = "10.1016/j.esmoop.2021.100158",

language = "אנגלית",

volume = "6",

journal = "ESMO Open",

issn = "2059-7029",

publisher = "BMJ Publishing Group",

number = "3",

}

Peleg Hasson, S, Brezis, MR, Shachar, E, Shachar, SS, Wolf, I & Sonnenblick, A 2021, 'Erratum to ‘Adjuvant endocrine therapy in HER2-positive breast cancer patients: systematic review and meta-analysis’: [ESMO Open Volume 6, Issue 2, April 2021, 100088] (ESMO Open (2021) 6(2), (S2059702921000454), (10.1016/j.esmoop.2021.100088))', ESMO Open, vol. 6, no. 3, 100158. https://doi.org/10.1016/j.esmoop.2021.100158

Erratum to ‘Adjuvant endocrine therapy in HER2-positive breast cancer patients : systematic review and meta-analysis’: [ESMO Open Volume 6, Issue 2, April 2021, 100088] (ESMO Open (2021) 6(2), (S2059702921000454), (10.1016/j.esmoop.2021.100088)). / Peleg Hasson, S.; Brezis, M. R.; Shachar, E. et al.

In: ESMO Open, Vol. 6, No. 3, 100158, 06.2021.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Erratum to ‘Adjuvant endocrine therapy in HER2-positive breast cancer patients

T2 - systematic review and meta-analysis’: [ESMO Open Volume 6, Issue 2, April 2021, 100088] (ESMO Open (2021) 6(2), (S2059702921000454), (10.1016/j.esmoop.2021.100088))

AU - Peleg Hasson, S.

AU - Brezis, M. R.

AU - Shachar, E.

AU - Shachar, S. S.

AU - Wolf, I.

AU - Sonnenblick, A.

PY - 2021/6

Y1 - 2021/6

N2 - The publisher regrets that at the time the article was published parts of Figure 2A and Figure 3 were missing. This has now been corrected and the correct figures appear below. [Figure presented] [Figure presented] The publisher would like to apologise for any inconvenience caused.

AB - The publisher regrets that at the time the article was published parts of Figure 2A and Figure 3 were missing. This has now been corrected and the correct figures appear below. [Figure presented] [Figure presented] The publisher would like to apologise for any inconvenience caused.

UR - http://www.scopus.com/inward/record.url?scp=85108674733&partnerID=8YFLogxK

U2 - 10.1016/j.esmoop.2021.100158

DO - 10.1016/j.esmoop.2021.100158

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???

C2 - 34144779

AN - SCOPUS:85108674733

SN - 2059-7029

VL - 6

JO - ESMO Open

JF - ESMO Open

IS - 3

M1 - 100158

ER -

Peleg Hasson S, Brezis MR, Shachar E, Shachar SS, Wolf I, Sonnenblick A. Erratum to ‘Adjuvant endocrine therapy in HER2-positive breast cancer patients: systematic review and meta-analysis’: [ESMO Open Volume 6, Issue 2, April 2021, 100088] (ESMO Open (2021) 6(2), (S2059702921000454), (10.1016/j.esmoop.2021.100088)). ESMO Open. 2021 Jun;6(3):100158. doi: 10.1016/j.esmoop.2021.100158

Erratum to ‘Adjuvant endocrine therapy in HER2-positive breast cancer patients: systematic review and meta-analysis’: [ESMO Open Volume 6, Issue 2, April 2021, 100088] (ESMO Open (2021) 6(2), (S2059702921000454), (10.1016/j.esmoop.2021.100088))

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this